The report noted that she's been treating her urticaria, commonly known as hives, with “allergen immunotherapy ... about 1% ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Please provide your email address to receive an email when new articles are posted on . Briquilimab targets c-Kit to address mast cell diseases. Patients saw substantial reductions in tryptase as ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 weeks of treatment, with responses as early as week 1, according to an ...

Allakos has announced a 75% workforce reduction and the discontinuation of its chronic spontaneous urticaria (CSU ... CSU – also known as chronic hives—compared the drug to a placebo.